Menopausal hormone therapy and cognition
- PMID: 30842090
- DOI: 10.1136/bmj.l877
Menopausal hormone therapy and cognition
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: PMM has received honorariums from Mylan for talks unrelated to the topic of this editorial. Further details of The BMJ policy on financial interests is here https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf
Comment on
-
Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study.BMJ. 2019 Mar 6;364:l665. doi: 10.1136/bmj.l665. BMJ. 2019. PMID: 30842086 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical